96 related articles for article (PubMed ID: 8545742)
21. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT; Studd JW; Watson NR; Holland EF
Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
Freeman EW; Sondheimer SJ; Rickels K; Albert J
J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
[TBL] [Abstract][Full Text] [Related]
23. [Effects of norethindrone on the premenstrual tension syndrome].
Neme B; Sampaio LF; Salomão AJ; dos Santos EP; von Atzingen IJ
Matern Infanc (Sao Paulo); 1970; 29(1):9-15. PubMed ID: 5534601
[No Abstract] [Full Text] [Related]
24. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol.
Nyberg S
Contraception; 2013 Jun; 87(6):773-81. PubMed ID: 23121822
[TBL] [Abstract][Full Text] [Related]
25. Premenstrual syndrome and migraine.
Allais G; Castagnoli Gabellari I; Burzio C; Rolando S; De Lorenzo C; Mana O; Benedetto C
Neurol Sci; 2012 May; 33 Suppl 1():S111-5. PubMed ID: 22644184
[TBL] [Abstract][Full Text] [Related]
26. Premenstrual syndrome.
Kwan I; Onwude JL
BMJ Clin Evid; 2015 Aug; 2015():. PubMed ID: 26303988
[TBL] [Abstract][Full Text] [Related]
27. [Premenstrual tension syndrome: current pathophysiologic and therapeutic concepts].
Gaspard U; Doyen J
Rev Med Brux; 1982 Nov; 3(9):595-604. PubMed ID: 6819626
[No Abstract] [Full Text] [Related]
28. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
Sangthawan M; Taneepanichskul S
Contraception; 2005 Jan; 71(1):1-7. PubMed ID: 15639064
[TBL] [Abstract][Full Text] [Related]
29. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
30. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
Borges LE; Andrade RP; Aldrighi JM; Guazelli C; Yazlle ME; Isaia CF; Petracco A; Peixoto FC; Camargos AF
Contraception; 2006 Dec; 74(6):446-50. PubMed ID: 17157100
[TBL] [Abstract][Full Text] [Related]
31. Premenstrual syndrome and dysmenorrhea in adolescents.
Allen LM; Lam AC
Adolesc Med State Art Rev; 2012 Apr; 23(1):139-63. PubMed ID: 22764560
[TBL] [Abstract][Full Text] [Related]
32. Premenstrual syndrome (PMS) in adolescents: severity and impairment.
Vichnin M; Freeman EW; Lin H; Hillman J; Bui S
J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):397-402. PubMed ID: 17174829
[TBL] [Abstract][Full Text] [Related]
33. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
[TBL] [Abstract][Full Text] [Related]
34. Psychological aspects of premenstrual syndrome.
Indusekhar R; Usman SB; O'Brien S
Best Pract Res Clin Obstet Gynaecol; 2007 Apr; 21(2):207-20. PubMed ID: 17175199
[TBL] [Abstract][Full Text] [Related]
35. [Triella: a French multicenter double blind clinical study].
Castaigne JP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
[TBL] [Abstract][Full Text] [Related]
36. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
[TBL] [Abstract][Full Text] [Related]
37. Indications for drug therapy in premenstrual syndrome patients.
Chihal HJ
J Reprod Med; 1987 Jun; 32(6):449-52. PubMed ID: 2956417
[TBL] [Abstract][Full Text] [Related]
38. Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
Fruzzetti F; Lazzarini V; Ricci C; Quirici B; Gambacciani M; Paoletti AM; Genazzani AR
Contraception; 2007 Sep; 76(3):190-4. PubMed ID: 17707715
[TBL] [Abstract][Full Text] [Related]
39. Role of bromocriptine and pyridoxine in premenstrual tension syndrome.
Sharma P; Kulshreshtha S; Singh GM; Bhagoliwal A
Indian J Physiol Pharmacol; 2007; 51(4):368-74. PubMed ID: 18476391
[TBL] [Abstract][Full Text] [Related]
40. Fluoxetine in the treatment of premenstrual syndrome.
Stone AB; Pearlstein TB; Brown WA
Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
